First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1.
Bacteriological Techniques
Clostridioides difficile
/ classification
Clostridium Infections
/ epidemiology
Cross Infection
/ epidemiology
Genotype
Hospitals
Humans
Lithuania
/ epidemiology
Minisatellite Repeats
Molecular Diagnostic Techniques
Molecular Epidemiology
Multilocus Sequence Typing
Pilot Projects
Prevalence
Ribotyping
Clostridioides difficile
Lithuania
MLST
MLVA
Ribotype 027
Surveillance
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
18
05
2019
accepted:
08
07
2019
pubmed:
22
7
2019
medline:
15
1
2020
entrez:
22
7
2019
Statut:
ppublish
Résumé
Clostridioides difficile has become the leading nosocomial Gram-positive pathogen in the developed countries. In Lithuania, the national surveillance program for C. difficile started in 2017. Enzyme immunoassay, the real-time PCR system, and culture are used for laboratory confirmation of C. difficile infection in Lithuanian clinical laboratories. No reference laboratory for C. difficile is present in Lithuania. Fifty-eight isolates of C. difficile were collected in 2016 and 2017 in two hospitals using real-time PCR and culture methods. Agarose gel-based PCR ribotyping, multilocus variable number tandem repeats analysis (MLVA), and multilocus sequence typing (MLST) were used for the genotypic characterization of 28 isolates. PCR ribotyping and MLST showed that 78.6% of the tested toxigenic isolates belong to the ribotype RT027/ST1. Using MLVA, 95.5% of RT027 isolates were genetically related. MLVA revealed three clonal complexes in RT027. Six non-RT027 isolates showed four different electrophoretic profiles in PCR ribotyping and were assigned to the MLST sequence types ST2, ST13, ST54, and ST63. The highest discriminatory power showed the genotyping by MLVA. In total, 20 MLVA profiles were identified. This genotyping technique allowed to identify four groups of RT027/ST1 isolates that were indistinguishable by PCR ribotyping and MLST. Our study is the first genotypic characterization of C. difficile isolates in Lithuania. We observed a high prevalence of presumptive RT027 that suggests unfavorable epidemiological situation in Lithuania. Our results stress for implementation of genotyping of C. difficile isolates in Lithuanian surveillance.
Identifiants
pubmed: 31327067
doi: 10.1007/s10096-019-03633-9
pii: 10.1007/s10096-019-03633-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1953-1959Références
Mol Biol Evol. 1999 Sep;16(9):1125-34
pubmed: 10486968
J Med Microbiol. 2008 Nov;57(Pt 11):1377-82
pubmed: 18927415
Euro Surveill. 2013 Jan 24;18(4):20381
pubmed: 23369393
Euro Surveill. 2016 Jul 21;21(29):
pubmed: 27470194
Anaerobe. 2016 Aug;40:95-9
pubmed: 27370902
J Med Microbiol. 2011 Aug;60(Pt 8):1112-8
pubmed: 21393454
J Clin Microbiol. 2016 Mar;54(3):775-8
pubmed: 26699700
Clin Microbiol Infect. 2016 Aug;22 Suppl 4:S63-81
pubmed: 27460910
PLoS One. 2017 Aug 16;12(8):e0182307
pubmed: 28813461
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28137804
J Clin Microbiol. 2010 Mar;48(3):770-8
pubmed: 20042623
Front Microbiol. 2017 Jan 11;7:2138
pubmed: 28123380
Annu Rev Microbiol. 2017 Sep 8;71:281-307
pubmed: 28657883
Clin Microbiol Infect. 2018 May;24(5):469-475
pubmed: 29274463
Microb Pathog. 2016 Aug;97:59-78
pubmed: 27238460
Clin Microbiol Infect. 2018 Jul;24(7):682-683
pubmed: 29505883
Genome Biol Evol. 2018 Mar 1;10(3):982-998
pubmed: 29617810
Lancet. 2011 Jan 1;377(9759):63-73
pubmed: 21084111
J Clin Microbiol. 2007 Mar;45(3):1024-8
pubmed: 17166961
Sci Rep. 2018 Mar 5;8(1):3992
pubmed: 29507300
FEMS Microbiol Lett. 1999 Jun 15;175(2):261-6
pubmed: 10386377
Front Microbiol. 2018 Mar 27;9:566
pubmed: 29636739
BMC Microbiol. 2013 Jun 05;13:126
pubmed: 23738754
Infect Drug Resist. 2018 Apr 06;11:489-500
pubmed: 29670381
J Clin Microbiol. 2013 Dec;51(12):4141-9
pubmed: 24108611
Euro Surveill. 2016 Jul 21;21(29):
pubmed: 27469624
J Clin Microbiol. 2016 Jan;54(1):13-8
pubmed: 26511734
Infect Genet Evol. 2017 Apr;49:1-11
pubmed: 28012982
PLoS One. 2011;6(5):e19993
pubmed: 21625511